Can We Use EBV-DNA Monitoring to Predict Disease Relapse in EBV-Positive Hodgkin Lymphoma Patients?

Publisher： Karger

E-ISSN： 1421-9662|124|1|23-26

ISSN： 0001-5792

Source： Acta Haematologica, Vol.124, Iss.1, 2010-07, pp. : 23-26

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Modeling HLA associations with EBV‐positive and ‐negative Hodgkin lymphoma suggests distinct mechanisms in disease pathogenesis

By  

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 5, 2015-09 ,pp. : 1066-1075

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systemic EBV‐positive lymphoproliferative disease of childhood

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : 355-355

John Wiley & Sons Inc

Access to resources Recommend Favorite

Systemic EBV‐positive lymphoproliferative disease of childhood

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 9, 2015-09 ,pp. : 849-849

John Wiley & Sons Inc

Access to resources Recommend Favorite

High incidence of Epstein–Barr virus (EBV)‐positive Hodgkin lymphoma and Hodgkin lymphoma‐like B‐cell lymphoproliferations with EBV latency profile 2 in children with interleukin‐2‐inducible T‐cell kinase deficiency

By  

HISTOPATHOLOGY, Vol. 67, Iss. 5, 2015-11 ,pp. : 607-616

John Wiley & Sons Inc

Access to resources Recommend Favorite

High incidence of Epstein–Barr virus (EBV)‐positive Hodgkin lymphoma and Hodgkin lymphoma‐like B‐cell lymphoproliferations with EBV latency profile 2 in children with interleukin‐2‐inducible T‐cell kinase deficiency

By  

HISTOPATHOLOGY, Vol. 309-0167, Iss. 5, 2015-11 ,pp. : 607-616

John Wiley & Sons Inc

Access to resources Recommend Favorite